Acceptability of cervical and anal hpv self-sampling in a sample of hispanic women in Puerto Rico

Puerto Rico Health Sciences Journal

Volumn 31, Issue 4, 2012, Pages 205-212

  Ortiz, Ana P ^a,b   Alejandro, Natalia ^c   Pérez, Cynthia M ^a   Otero, Yomayra ^a   Soto Salgado, Marievelisse ^b   Palefsky, Joel M ^d   Tortolero Luna, Guillermo ^b   Romaguera, Josefina ^c  

^a UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acceptability; Anus; Cervix; HPV; Self sampling

Indexed keywords

ADOLESCENT; ADULT; ANAL CANAL; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HISPANIC; HUMAN; MASS SCREENING; METHODOLOGY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PUERTO RICO; SELF CARE; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANAL CANAL; CERVIX UTERI; CROSS-SECTIONAL STUDIES; FEMALE; HISPANIC AMERICANS; HUMANS; MASS SCREENING; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PUERTO RICO; SELF CARE; VAGINAL SMEARS; YOUNG ADULT;

EID: 84871067378     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. (2011). A Review of Human Carcinogens: Biological Agents. Lyon, France: International Agency for Research on Cancer. Vol. 100B. Avail-able at: Url: http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B.pdf
2. Joseph DA, Miller JW, Wu X, et al. Understanding the Burden of Human Papillomavirus-associated Anal Cancers in the US. Cancer 2008;113(10 Suppl):2892-900.
3. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States 1998-2003. Cancer 2008;113(10 Suppl):2855-64.
4. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Re-view, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, based on November 2011 SEER data submission. Avail-able at: Url: http://seer.cancer.gov/csr/1975_2009_pops09/index.html. Accessed October 12, 2012.
5. Moscicki AB, Palefsky JM. Human papillomavirus in men: an update. J Low Genit Tract Dis 2011;15:231-4.
6. Ortoski RA, Kell CS. Anal Cancer and Screening Guidelines for Human Papillomavirus in Men. J Am Osteopath Assoc 2011;111(3 suppl 2): S35-S43.
7. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Epi-demiology and burden of HPV infection and related diseases: Implications for prevention strategies. Prev Med 2011;53 Suppl 1:S12-21.
8. Zhao FH, Lewkowitz AK, Chen F, et al. Pooled Analysis of a Self-Sam-pling HPV DNA Test as a Cervical Cancer Primary Screening Method. J Natl Cancer Inst 2012;104:178-88.
9. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cer-vical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999; 281:1605-10.
10. Franco EL, Ferenczy A. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to papanicolaou smear in the triage of women with cervical cytologic abnormalities. Am J Obstet Gy-necol 1999;181:382-6.
11. ACOG Committee on Practice Bulletins--Gynecology. ACOG Prac-tice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol 2009;114:1409-20.
12. Lampinen TM, Chan K, Anema A, Kornegay J, Hogg RS, Coutlee F. Self-Screening for Rectal Sexually Transmitted Infections: Human Papilloma-virus. Clin Infect Dis 2006;42:308-9.
13. Farley M, Golding JM, Minkoff JR. Is a history of trauma associated with a reduced likelihood of cervical cancer screening? J Fam Pract 2002;51: 827-31.
14. Hislop TG, Deschamps M, Teh C, et al. Facilitators and barriers to cer-vical cancer screening among Chinese Canadian women. Can J Public Health 2003;94:68-73.
15. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: Self-sampling versus clinician directed-biological concordance and women's preferences. Am J Obstet Gynecol 2002;186:365-73.
16. Chin-Hong PV, Berry JM, Cheng S-C, et al. Comparison of patient- and clinician-collected anal cytology samples to screen for human papilloma-virus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008;149:300-6.
17. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC Jr. Accept-ability of Self-Collection of Specimens for HPV DNA Testing in an Urban Population. J Womens Health 2005;14:721-8.
18. Cranston RD, Darragh TM, Holly EA, et al. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neopla-sia in HIV-positive men. J Acquir Immune Defic Syndr 2004;36:915-20.
19. Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: A meta-analysis. Sex Transm Infect 2005;81:207-12.
20. Gravitt PE, Lacey JV Jr, Brinton LA, et al. Evaluation of Self-Collected Cervicovaginal Cell Samples for Human Papillomavirus Testing by Polymerase Chain Reaction. Cancer Epidemiol Biomarkers Prev 2001;10: 95-100.
21. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81-6.
22. Ortiz AP, Romaguera J, Pérez C, et al. Human papillomavirus infection in women in Puerto Rico: Agreement between physician- versus self-collected anogenital specimens. J Low Genit Tract Dis 2013;17(In press).
23. Igidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M. Self-collected human papillomavirus testing acceptability: Comparison of two self-sampling modalities. J Womens Health 2011;20:397-402.
24. Barbee L, Kobetz E, Menard J, et al. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes Control 2010;21:421-31.
25. Waller J, McCaffery K, Forrest S, et al. Acceptability of unsupervised HPV self-sampling using writing instructions. J Med Screen 2006;13:208-13.
26. Deleré Y, Schuster M, Vartazarowa E, et al. Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papil-lomavirus genotypes in women aged 20 to 30 years. J Clin Microbiol 2011;49:3519-22.
27. Marlow LA, Waller J, Wardle J. Sociodemographic predictors of HPV testing and vaccination acceptability: Results from a population-repre-sentative sample of British women. J Med Screen 2008;15:91-6.
28. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the accept-ability of two self-sampling devices for human papillomavirus testing in the cervical screening context: A qualitative study of Muslim women in London. J Med Screen 2009;16:193-8.
29. Barata PC, Mai V, Howlett R, Gagliardi AR, Stewart DE. Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention. J Psychosom Obstet Gynaecol 2008;29:251-7.
30. Forrest S, McCaffery K, Waller J, et al. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester. J Med Screen 2004;11:85-8.
31. Rosenberger JG, Dodge D, Van Der Pol B, Reece M, Herbenick D, Fortenberry JD. Reactions to self-sampling for ano-rectal sexually transmitted infections among men who have sex with men: A qualitative study. Arch Sex Behav 2011;40:281-8.
32. Colón-López V, Ortiz AP, Palefsky J. Burden of human papillomavirus infection and related comorbidities in men: Implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J 2010;29:232-40.
33. Marlow LA, Wardle J, Forster AS, Waller J. Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Community Health 2009;63:1010-5.
34. Monsonego J, Cortes J, Greppe C, Hampl M, Joura E, Singer A. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. Vaccine 2010;28: 8065-72.
35. Dzuba IG, Díaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002;11:265-75.
36. Chang C, Tseng CJ, Liu WW, et al. Clinical Evaluation of A New Model of Self-Obtained Method for the Assessment of Genital Human Papil-loma Virus Infection in an Underserved Population. Chang Gung Med J 2002;25:664-71.
37. Kahn JA, Bernstein DI, Rosenthal SL, et al. Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect 2005;81:408-14.
38. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
39. Ortiz AP, Hebl S, Serrano R, Fernandez ME, Suárez E, Tortolero-Luna G. Factors associated with cervical cancer screening in Puerto Rico. Prev Chronic Dis 2010;7:A58.
40. Mercer BM, Taylor MC, Fricke JL, Baselski VS, Sibai BM. The accuracy and patient preference for self-collected group B Streptococcus cultures. Am J Obstet Gynecol 1995;173:1325-8.
41. Calore EE, Giaccio CM, Nadal SR. Prevalence of anal cytological ab-normalities in women with positive cervical cytology. Diagn Cytopathol 2011;39:323-7.
42. Edgren G, Sparén P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: A prospective population-based study. Lancet Oncol 2007;8:311-6.
43. Szarewski A, Cadman L, Mallett S, et al. Human papillomavirus testing by self-sampling: Assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007;14:34-42.
44. Gök M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010;340:c1040. doi: 10.1136/bmj.c1040.
45. Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alterna-tive strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer 2011;104:915-20.